SOURCE: Cypress Bioscience, Inc.

February 13, 2009 06:30 ET

Cypress Bioscience, Inc. to Present at Roth Capital Partners 21st Annual OC Growth Stock Conference

SAN DIEGO, CA--(Marketwire - February 13, 2009) - Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Sabrina Martucci Johnson, its Chief Operating Officer and Chief Financial Officer, will present at the ROTH Capital Partners 21st Annual OC Growth Stock Conference on February 17, 2009.

The ROTH conference is being held at the Ritz Carlton in Laguna Niguel, CA. Ms. Johnson is scheduled to present on Tuesday, February 17th at 1:00 p.m. Pacific Time. The audio broadcast of this presentation can be accessed at http://www.wsw.com/webcast/roth20/cypb/.

A replay of the presentation will be available at the same web address as well as on Cypress' website, http://www.cypressbio.com/news/events.php.

About Cypress Bioscience

Cypress Bioscience, Inc. provides therapeutics and personalized medicine services, facilitating improved and individualized patient care. Cypress addresses the evolving needs of specialist physicians and their patients by identifying unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders such as fibromyalgia and rheumatoid arthritis. This approach to improving patient care creates a unique partnership with physicians.

For more information about Cypress, please visit the Company's website at www.cypressbio.com.

Contact Information

  • For additional information please contact

    Ciara Kennedy
    Senior Director Strategy & Corporate Development
    Mary Gieson
    Investor Relations
    (858) 452-2323
    Email Contact